Spencer Hawkswell

<p>In the latest episode of the Psychedelic Spotlight podcast, we speak with Spencer Hawkswell who is the CEO of TheraPsil, a non-profit coalition of healthcare professionals, patients, and advocates dedicated to obtaining legal access to psilocybin-assisted psychotherapy for Canadians in medical need.</p><p>In our conversation with Spencer, we discuss the different challenges he and the TheraPsil team are focused on overcoming to increase access to psilocybin-assisted psychotherapy for patients in Canada suffering through end-of-life distress, and why psilocybin, in particular, is capable of offering certain patients relief from their suffering.</p><p>*To learn more about the company discussed in this episode and the work they’re doing, visit their website: <a href="https://therapsil.ca">TheraPsil.ca</a></p><p>*Subscribe to our newsletter to get the latest industry news: <a href="https://psychedelicspotlight.com/">PsychedelicSpotlight.com</a></p><p>Instagram: <a href="https://www.instagram.com/psycspotlight">@PsycSpotlight</a></p><p>Twitter: <a href="https://twitter.com/PsycSpotlight">@PsycSpotlight</a></p><p>Facebook: <a href="https://www.facebook.com/PsychedelicSpotlight">PsychedelicSpotlight</a></p><p>YouTube: <a href="https://bit.ly/3prTiCI">PsychedelicSpotlight</a></p><p>LinkedIn: <a href="https://www.linkedin.com/company/psychedelic-spotlight">Psychedelic-Spotlight</a></p><p>*This interview was recorded on July 20, 2021.</p>